You have spent the last three weeks deep-diving into the quarterly earnings of a leading infrastructure firm. Your valuation model is nearly complete, and you are preparing to publish a ‘Buy’ recommendation that is likely to move the stock price upon release. Suddenly, a personal financial emergency arises, and you need to liquidate your holdings in this very company to cover the cost. You pause, remembering the SEBI restrictions, and realize that navigating these rules is not merely an administrative hurdle; it is the cornerstone of your professional reputation.
Regulation 16 of the SEBI (Research Analysts) Regulations imposes strict blackout periods on trading to prevent front-running and conflict of interest. A research analyst is prohibited from dealing in securities recommended in their reports for 30 days before publication and 5 days after. This ‘quiet period’ ensures that your analysis remains objective and that you do not profit from the market impact caused by your own proprietary research.
Without this firewall, an analyst might be tempted to issue a positive report solely to boost the liquidity or price of a position they already hold, a clear violation of fiduciary duty.
However, these regulations are not absolute. The law provides narrow exceptions for situations where the analyst faces genuine financial hardship or unforeseen circumstances that necessitate an immediate liquidation of positions. In such cases, the analyst must secure written approval from their firm’s Compliance Officer. The burden of proof lies with the analyst to demonstrate that the transaction is not motivated by the research content, but by a legitimate, unavoidable personal exigency.
Consider an analyst who holds shares in an IT company for years, well before initiating coverage. If that analyst is suddenly forced to pay for a medical emergency or fulfill a legal settlement, they cannot simply sell the shares if a report is due soon. Instead, they must disclose the intent to the compliance department, undergo a review process, and receive explicit clearance.
This process protects the firm from allegations of insider trading while allowing the analyst to manage personal crises. Every transaction record must be maintained in a register, ensuring full transparency for SEBI audits, as these documents are the primary evidence of your adherence to the regulatory code.
Nuance
Check Your Understanding
An analyst plans to publish a research report on a pharmaceutical company on October 20th. Due to an unforeseen personal financial emergency, the analyst wishes to sell their existing holdings in this company on October 10th. Under SEBI regulations, what is the mandatory course of action?
Which of the following best describes the primary intent of the 30-day and 5-day trading restrictions for research analysts?
This is a companion read for Section 14.4 — Management of Conflicts of Interest and Disclosure Requirements for Research Analysts from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.